A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer
Sara Bobisse, Valentina Bianchi, János L. Tanyi, Apostolos Sarivalasis, Edoardo Missiaglia, Rémy Pétremand, Fabrizio Benedetti, Drew A. Torigian, Raphaël Genolet, David Barras, Alexandra Michel, Spyridon Mastroyannis, Emese Zsíros, Denarda Dangaj Laniti, Zoi Tsourti, Brian J. Stevenson, Christian Iseli, Bruce L. Levine, Daniel E. Speiser, David Gfeller, Michal Bassani‐Sternberg, Daniel J. Powell, Carl H. June, Urania Dafni, Lana E. Kandalaft, Alexandre Harari, George Coukos
Topics & Concepts
Adoptive cell transferOvarian cancerEx vivoMedicineImmunologyEpitopeImmunityImmune systemCancerCancer vaccineVaccinationT cellImmunotherapyCancer researchIn vivoAntibodyInternal medicineBiologyBiotechnologyImmunotherapy and Immune ResponsesCAR-T cell therapy researchVirus-based gene therapy research